Average Co-Inventor Count = 7.72
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Aktiengesellschaft (36 from 12,160 patents)
2. Bayer Healthcare Aktiengesellschaft (7 from 76 patents)
3. Bayer Pharma Aktiengesellschaft (2 from 378 patents)
4. Bayer Schering Pharma Ag (2 from 192 patents)
5. Bayer Pharmaceuticals Corporation (1 from 70 patents)
6. Bayer Aktlengesellschaft (1 from 1 patent)
7. Adverio Pharma Gmbh (21 patents)
49 patents:
1. 7704999 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
2. 7696206 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
3. 7314871 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
4. 7276504 - Use of 2-alkoxyphenyl-substituted imidazotriazinones
5. 7173037 - Carbamate-substituted pyrazolopyridines
6. 7135474 - Derivatives of 2-(1-benzyl-1H-pyrazolo(3,4-B)pyridine-3-yl)-5(-4-pyridinyl)l-4-pyrimidinamines and the use thereof as quanylate cyclase stimulators
7. 7122540 - 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
8. 7098207 - Imidazotriazinones and the use thereof
9. 7091203 - Imidazo[1,3,5]triazinones and their use
10. 7074780 - Substituted phenylcyclohexanecarboxamides and their use
11. 6984642 - Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
12. 6943163 - 7-Alkyl and cycloalkyl-substituted imidazotriazinones
13. 6930108 - Use of 2-alkoxyphenol-substituted imidazotriazinones
14. 6890922 - 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
15. 6878708 - Imidazotriazinones and the use thereof